{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2011"],"condition":["Colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2621130"],"location":["Japan"],"study_start_month":["7"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Phase II trial of adjuvant mFOLFOX6 after metastasectomy for lung metastasis of colorectal cancer","description":"Interventions: Fluororacil/l-leucovorin plus oxaliplatin (mFOLFOX6)\nPrimary outcome(s): 5-year survival rate\nStudy Design: Single arm Non-randomized","dates":{"creation":"2011-07-15"},"accession":"2621130","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000005693"]}}